UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery
UC Dept. of Surgery		 UC Dept. of Surgery


Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Dutasteride 0.5 mg Administered Orally Once daily for Four Years to Reduce the Risk of Biopsy-Detectable Prostate Cancer. Sponsor: Glaxo-SmithKline. Study enrollment open. Principal Investigator: R. Bruce Bracken, M.D.


Study of Duloxetine HCl in Women of Different Demographic Characteristics and Co-morbidities with Stress Urinary Incontinence: Evaluation of Efficacy and Safety. Sponsor: Lilly & Boehringer Ingelheim. Study Enrollment open. Principal Investigator: R. Bruce Bracken, M.D.

The Effects of Refecoxibin in Reducing the Risk of Prostate Cancer (VIP Study). Sponsor: Merck & Co. Study enrollment open. Principal Investigator: R. Bruce Bracken, M.D.

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Immunotherapy with Autologous Antigen-Presenting Cells Loaded with PA2024 (Provenge, ACP8015) in Asymptomatic Patients with Gleason Sum <7, Metastatic, Androgen Independent Prostatic Adenocarcinoma. Sponsor: Dendreon Corporation. Study enrollment open. Principal Investigator: R. Bruce Bracken, M.D.


If you are interested in participating in one of these clinical trials, please contact:

Barbara Burke
Division of Urology
burkeb@ucmail.uc.edu
(513) 558-4060
UC Surgeons logo privacy statement